Empowering the inventor--the case of monoclonal antibodies.
Academic ownership of intellectual property facilitated wide dissemination and commercialization of antibody technology. Moves at the University of Cambridge to reclaim institutional IP rights should thus be treated with caution.
Clark
Mike
M
University of Cambridge, Department of Pathology, Tennis Court Road, Cambridge CB2 1QP, UK. mrc7@cam.ac.uk
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000627:therapeutic use; D001690:Biological Science Disciplines / Q000331:legislation & jurisprudence / Q000379:methods; D001709:Biotechnology / Q000331:legislation & jurisprudence / Q000639:trends; D006801:Humans; D033181:Information Dissemination; D018973:Intellectual Property; D010330:Patents as Topic; D012109:Research Support as Topic; D018581:Technology Transfer
D000911:Antibodies, Monoclonal